New targeted therapy for advanced colorectal cancer given NICE approval

Getty/peterschreiber.media

By Sarah Lowden

A new treatment for advanced colorectal cancer has been given draft approval by the National Institute for Health and Care Excellence.

It combines two immunotherapies - nivolumab (Opdivo) and ipilimumab (Yervoy).